The Latest Breaking News from JDRF

More than 200 people will put themselves to the test on June 3, with supporters urged to turn out and raise money for the Juvenile Diabetes Research Foundation (JDRF)

Hannah Crabtree got active on Twitter in 2016 to find more people like herself: those with Type 1 diabetes who’d hacked their insulin pumps to automatically adjust the amount of insulin delivered.

In a first, the U.S. Food and Drug Administration has approved a therapy that slows the onset of Type 1 diabetes. Teplizumab, developed by Provention Bio, typically delays the need for insulin shots, blood-sugar monitoring, and diet control by about two years. For some, the effect lasted years longer.

The game at Meadow Park was organised to raise funds for Juvenile Diabetes Research Foundation (JDRF)

Soenaid Anderson organised the fundraiser ahead of running the London Marathon in October

Here's a roundup of top developments in the biotech space over the last 24 hours:

Mitchell Carling, 14, was one of the lucky fans to score tickets for the Europa League Final on Wednesday, May 18 but has decided to sacrifice his tickets for causes close to his heart.

Gers-daft Mitchell Carling, 14, was lucky enough to score tickets for the game but has now chosen to sacrifice them for a good cause.

Steve Morgan, who was born in Liverpool, has made the largest-ever single gift in the UK for diabetes research